|
IFIH1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.722860E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.417990E-03 |
| Normal-vs-Stage2 |
3.986600E-01 |
| Normal-vs-Stage3 |
1.202570E-01 |
| Normal-vs-Stage4 |
1.524430E-01 |
| Stage1-vs-Stage2 |
3.595400E-01 |
| Stage1-vs-Stage3 |
5.389400E-01 |
| Stage1-vs-Stage4 |
9.605600E-01 |
| Stage2-vs-Stage3 |
7.165600E-01 |
| Stage2-vs-Stage4 |
5.023800E-01 |
| Stage3-vs-Stage4 |
6.439000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.361080E-04 |
| Normal-vs-AfricanAmerican |
4.067600E-01 |
| Normal-vs-Asian |
9.984000E-01 |
| Caucasian-vs-AfricanAmerican |
2.090000E-02 |
| Caucasian-vs-Asian |
2.486200E-01 |
| AfricanAmerican-vs-Asian |
7.637600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.227560E-04 |
| Normal-vs-Female |
6.416800E-01 |
| Male-vs-Female |
2.660800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.158600E-04 |
| Normal-vs-Extreme_Weight |
3.92409999999677E-05 |
| Normal-vs-Obese |
3.593000E-01 |
| Normal-vs-Extreme_Obese |
2.775800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.287400E-01 |
| Normal_Weight-vs-Obese |
2.207700E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.926600E-01 |
| Extreme_Weight-vs-Obese |
1.495720E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.409400E-01 |
| Obese-vs-Extreme_Obese |
5.838200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.563600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.123800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.007850E-04 |
| Normal-vs-Age(81-100Yrs) |
2.425000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.400200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.128220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.271400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.957740E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.759000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.615800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.576910E-04 |
| Normal-VS-Type2 PRCC |
9.210200E-02 |
| Normal-VS-KIRP CIMP |
6.142000E-01 |
| Normal-VS-Unclassified PRCC |
8.823400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.159800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.018200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.392170E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.515400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.898600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.510200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.364300E-03 |
| Normal-vs-N1 |
8.095800E-01 |
| Normal-vs-N2 |
6.838200E-03 |
| N0-vs-N1 |
8.277700E-02 |
| N0-vs-N2 |
1.499380E-01 |
| N1-vs-N2 |
1.423140E-03 |
|
|
